S.Res. 732
Referred to CommitteeA resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Latest Action
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310)
5/14/2026 • Senate
Summary
Congress.gov has not published an official summary of this bill yet.
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (47)
Party Breakdown
Sponsor
Cosponsors (46)
Bill Journey
Originated in the Senate
Introduced
May 14, 2026
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310)
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Details
Sources and method
· Congress.gov, USAspending, FEC, LDA · Record updated May 29, 2026
- Congress.govLibrary of CongressStatus, actions, sponsors, cosponsors, committees and textRecord updated May 29, 2026 · Loaded Oct 31, 2026, 3:28 PM ET
- USAspending.govU.S. Department of the TreasuryRelated Federal Spending section
- FEC filingsFederal Election CommissionFunding & Lobbying section
- Lobbying disclosures (LDA)Secretary of the Senate and Clerk of the HouseFunding & Lobbying section
All sources: Public domain (17 U.S.C. § 105) · Method: Data sources → · Campaign finance →
AI-written text on this page is labeled where it appears. It is written from the sources above and is not a source itself. How we analyze data →
Dates shown where the source reports one. “Loaded” is when CIV.IQ last fetched the record.